The addition of sera from healthy controls, patients with PsC and PGRN Ab-negative patients with PsA reduced TNF-α-induced cytotoxicity of WEHI-S and HT-1080 cells to a significantly higher degree than in the sera of PGRN Ab-positive patients with PsA. The gene discussed is GRN; the disease is pancreatic serous cystadenoma.